Injective: MiCA whitepaper for INJ filed and listed in ESMA's Interim Register - 25 Sep 2026

Injective has filed a MiCA whitepaper for INJ, and the document is now listed in ESMA's Interim MiCA Register. The filing creates a direct path toward regulated INJ access across 30 EU markets, giving European investors a compliance framework for the token.The listing in ESMA's Interim MiCA Register is a filing-stage step rather than a final authorization. Repricing tied to the event therefore depends on subsequent EU authorization outcomes, which determine whether regulated access actually opens. If later approvals follow, exchanges and custodians in the 30 covered markets gain a clearer basis to offer INJ under a harmonized rulebook, reducing the legal uncertainty that has kept some European venues on the sidelines.The MiCA whitepaper for has been filed and is now listed in ESMA’s Interim MiCA Register.This creates a direct path to accelerate regulated access across 30 EU markets.Injective's global expansion is underway.